First in Human Single Ascending Dose Study of MOR107

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is the first in human study of MOR107. It is a 2 part, single centre, double-blind, randomised, placebo-controlled study in healthy male subjects. Part 1 is a single ascending dose study, and Part 2 is a parallel group, dose range finding study in healthy male subjects on a low sodium diet.
Epistemonikos ID: 1dc1d5f1a42d1d85135ad2d7d83b14f22037ebd5
First added on: May 20, 2024